INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Human Abuse Potential: Subjective Ratings]( "Human Abuse Potential: Subjective Ratings")
Human Abuse Potential: Subjective RatingsAccurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
-
![GettyImages-2148428939-computer-business-woman-office]( "Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere")
Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures EverywhereOvercome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.
-
![20 20 onsite]( "Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular Endpoints")
Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular EndpointsReduce operational risk in ophthalmic trials with point-of-need execution. Discover how mobile clinics, specialized teams, and single-call accountability protect endpoint quality and study timelines.
-
![GettyImages-1744064144-pencil-hand-automation-gears-ai]( "Automation Testing In RTSM Software: What Is It And What's The Impact")
Automation Testing In RTSM Software: What Is It And What's The ImpactMove beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy3/17/2026
Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
-
Bring RTSM In A Protocol Synopsis: Here's Why3/25/2026
Learn how early feedback from experienced teams can reveal hidden protocol and logistical risks, helping sponsors refine decisions and avoid avoidable challenges long before the final protocol is set.
-
Protocol Design Choices That Trigger IRB And Regulatory Requirements8/20/2026
Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
The Importance Of Diversity In Clinical Trials10/16/2024
A recent FDA draft guidance aims to address health disparities and enhance data quality with action plans for greater inclusivity in clinical trials. Explore practical steps to building trust and inclusivity in clinical research.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials8/11/2025
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Action plan GettyImages-512704624]( "Informed Diversity Action Planning Made Simple")
Develop effective, data-driven Diversity Action Plans tailored to your specific clinical needs with the help of an expert consulting and analytics team.
-
![GettyImages-1311429557-vaccine-shot]( "The #1 Rated Leader In DCT Now Offers The Vaccine Pathway")
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
![GettyImages-1181024482 payment]( "Site And Patient Payments")
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
-
![Science technology, Research and Development, Drug discovery-GettyImages-1209661917]( "Purposed-Built For ADC Development")
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
![GettyImages-1971327276 doctor patient]( "Balancing The Scales: The Strategic Role Of Stipends In Trial Success")
Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.
